In a transcriptome profiling analysis, MPA affected the proliferation of cancer gastric cells in a PI3K-AKT-mTOR pathway-dependent manner1, 24, and in a gastric adenocarcinoma cell line, MPA decreased the activity of AKT and mTOR after 48 h and 72 h of treatment. The gene discussed is MTOR; the disease is cancer.